PYXS · NASDAQ
Pyxis Oncology (PYXS) Stock Price & Fundamentals
Pyxis Oncology (PYXS) closed at $721.09 on Oct 9, 2026, up 0.35% from the previous close of $718.61.
Share price, past year
1Y +33.78%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $721.09 |
| Sep 30, 2026 | $706.25 |
| Aug 31, 2026 | $654.91 |
| Jul 31, 2026 | $603.77 |
| Jun 30, 2026 | $595.12 |
| May 29, 2026 | $568.34 |
| Apr 30, 2026 | $580.94 |
| Mar 31, 2026 | $554.32 |
| Feb 27, 2026 | $553.81 |
| Jan 30, 2026 | $575.65 |
| Dec 31, 2025 | $568.68 |
| Nov 28, 2025 | $561.53 |
| Oct 31, 2025 | $549.77 |
Key statistics
- Market cap
- $45.74B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.40
- Revenue (TTM)
- —
- Net income (TTM)
- −$88.73M
- Shares outstanding
- 63.4M
- Dividend yield
- —
- 52-week range
- $535.57 – $721.09
Pyxis Oncology's market cap is $45.74B, based on a share price of $721.09 and 63.4M shares outstanding as of Jun 30, 2026.
Financials
Pyxis Oncology reported revenue of $13.86M for fiscal 2025, down 14.17% from fiscal 2024.
Pyxis Oncology reported a net loss of $79.62M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $13.86M | −14.2% | −$79.62M | −574.6% | −$1.28 | −$63.51M |
| FY2024ended Dec 31, 2024 | $16.15M | — | −$77.33M | −479.0% | −$1.32 | −$57.91M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2025ended Jun 30, 2025 | $2.82M | −$18.35M | −$0.30 |
| Q1 FY2024ended Mar 31, 2024 | $16.15M | — | — |
Company profile
- Name
- Pyxis Oncology, Inc.
- Ticker
- PYXS
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 321 Harrison Avenue, Boston, MA 02118
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001782223
Recent SEC filings
- Oct 1, 2026
- Sep 9, 2026
- Sep 8, 2026
- Aug 13, 2026
- Aug 13, 2026
- Jul 2, 2026
- Jun 15, 2026
- May 14, 2026
Frequently asked questions
What is Pyxis Oncology's stock price?
Pyxis Oncology (PYXS) closed at $721.09 on Oct 9, 2026, up 0.35% from the previous close of $718.61.
What is Pyxis Oncology's market cap?
Pyxis Oncology's market cap is $45.74B, based on a share price of $721.09 and 63.4M shares outstanding as of Jun 30, 2026.
How much revenue does Pyxis Oncology make?
Pyxis Oncology reported revenue of $13.86M for fiscal 2025, down 14.17% from fiscal 2024.
Does Pyxis Oncology pay a dividend?
Pyxis Oncology's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Pyxis Oncology, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures